Novel anti-inflammatory peptide alleviates liver ischemia-reperfusion injury
Loading...
Date
2024-04-30
Journal Title
Journal ISSN
Volume Title
Publisher
Journal of Biomedical Research
Abstract
Ischemia-reperfusion injury (IRI) remains inevitable in liver surgeries, macrophages play a critical role in the development of IRI, but little is known about the macrophages regulate pathogenesis of IRI. Based on target guided screening, we identified a small 3 kDa peptide (SjDX5-271) from various schistosome egg-derived peptides that induced M2 macrophage polarization. SjDX5-271 treatment protected the mice against liver IRI through promoting M2 macrophage polarization, the protective effect was abrogated when the macrophages were depleted. Transcriptomic sequencing showed that the TLR signaling pathway was significantly inhibited in macrophages derived from the SjDX5-271 treatment group. We further identified that SjDX5-271 promotes M2 macrophage polarization by inhibiting the TLR4/MyD88/NF-κB signaling pathway and further alleviates hepatic inflammation in liver IRI. Collectively, SjDX5-271 exhibits promising therapeutic effects in IRI and represents a novel therapeutic approach for IRI, even in immune-related diseases. This study revealed the development of a new biologic from the parasite and enhanced our understanding of host-parasite interplay, providing a blueprint for future therapies for immune-related diseases.
Description
Keywords
Schistosome-derived peptide, Liver ischemia-reperfusion injury, Macrophage, Toll-like receptor-4
Citation
Xu, X., Sun, K., Chang, H., Shen, C., Li, X., Ni, Y., ... & Ji, M. (2024). Novel anti-inflammatory peptide alleviates liver ischemia-reperfusion injury. The Journal of Biomedical Research. https://doi.org/10.7555/JBR.38.20240020